Your browser doesn't support javascript.
loading
Establishment of NF-κB sensing and interleukin-4 secreting mesenchymal stromal cells as an "on-demand" drug delivery system to modulate inflammation.
Lin, Tzuhua; Pajarinen, Jukka; Nabeshima, Akira; Lu, Laura; Nathan, Karthik; Yao, Zhenyu; Goodman, Stuart B.
Afiliação
  • Lin T; Department of Orthopaedic Surgery, Stanford University, Stanford, California, USA.
  • Pajarinen J; Department of Orthopaedic Surgery, Stanford University, Stanford, California, USA.
  • Nabeshima A; Department of Orthopaedic Surgery, Stanford University, Stanford, California, USA.
  • Lu L; Department of Orthopaedic Surgery, Stanford University, Stanford, California, USA.
  • Nathan K; Department of Orthopaedic Surgery, Stanford University, Stanford, California, USA.
  • Yao Z; Department of Orthopaedic Surgery, Stanford University, Stanford, California, USA.
  • Goodman SB; Department of Orthopaedic Surgery, Stanford University, Stanford, California, USA; Department of Bioengineering, Stanford University, Stanford, California, USA. Electronic address: goodbone@stanford.edu.
Cytotherapy ; 19(9): 1025-1034, 2017 09.
Article em En | MEDLINE | ID: mdl-28739167
ABSTRACT
Chronic inflammation is associated with up-regulation of the transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and excessive inflammatory cytokine secretion by M1 macrophages. The anti-inflammatory cytokine interleukin (IL)-4 converts pro-inflammatory M1 macrophages into an anti-inflammatory and tissue-regenerative M2 phenotype, thus reducing inflammation and enhancing tissue regeneration. We have generated NF-κB responsive, or constitutively active IL-4 expression lentiviral vectors transduced into murine bone marrow-derived mesenchymal stromal cells (MSCs). MSCs with a constitutively active IL-4 expression vector produced large quantities of IL-4 continuously, whereas IL-4 secretion was significantly induced by lipopolysaccharide (LPS) in the NF-κB sensing MSCs. In contrast, LPS had no effect on MSCs with IL-4 secretion driven by a constitutively active promoter. We also found that intermittent and continuous LPS treatment displayed distinct NF-κB activation profiles, and this regulation was independent of IL-4 signaling. The supernatant containing IL-4 from the LPS-treated MSCs suppressed M1 marker (inducible nitric oxide synthase [iNOS] and tumor necrosis factor alpha [TNFα]) expression and enhanced M2 marker (Arginase 1, CD206 and IL1 receptor antagonist [IL1Ra]) expression in primary murine macrophages. The IL-4 secretion at the basal, non-LPS induced level was sufficient to suppress TNFα and enhance Arginase 1 at a lower level, but had no significant effects on iNOS, CD206 and IL1Ra expression. Finally, IL-4 secretion at basal or LPS-induced levels significantly suppressed osteogenic differentiation of MSCs. Our findings suggest that the IL-4 secreting MSCs driven by NF-κB sensing or constitutive active promoter have great potential for mitigating the effects of chronic inflammation and promoting earlier tissue regeneration.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: NF-kappa B / Interleucina-4 / Sistemas de Liberação de Medicamentos / Células-Tronco Mesenquimais Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: NF-kappa B / Interleucina-4 / Sistemas de Liberação de Medicamentos / Células-Tronco Mesenquimais Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article